Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06048731
Other study ID # PSR: EV-ICD PAS/PMCF
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2023
Est. completion date October 31, 2037

Study information

Verified date June 2024
Source Medtronic
Contact EV-ICD PAS/PMCF Study manager
Phone 18006338766
Email rs.productsurveillanceregistry@medtronic.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices.


Description:

The Enlighten Study is a global, prospective, observational, multi-site registry study. This study is conducted within Medtronic's post-market surveillance platform. Eligibility for enrollment is based on market release dates for EV-ICD System within the geography in which the subject is enrolled. Patients enrolled in the Enlighten Study will be prospectively followed for the life time of device post-implant or until registry closure, patient death or patient exit from the registry (i.e., withdrawal of consent). Successfully implanted patients are expected to have scheduled follow-up visits approximately every 6 months, but at least annually, or as prompted by reportable adverse events. The total estimated registry duration is is through lifetime of device.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date October 31, 2037
Est. primary completion date May 31, 2030
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements - Patient is intended to receive or be treated with a EV-ICD device System and must be enrolled prior to the EV-ICD device implant procedure Exclusion Criteria: - Patient who is, or is expected to be, inaccessible for follow-up - Patient is excluded by local local law - Patient is currently enrolled or plans to enroll in any concurrent drug and/or device study that may confound the PSR results

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Defibrillation using EV-ICD
Device: Defibrillation using the Extravascular ICD (EV-ICD)

Locations

Country Name City State
Austria LKH - Universitätsklinikum Graz Graz
Austria Aö Landeskrankenhaus - Universitätskliniken Innsbruck Innsbruck
Austria Kepler Universitätsklinikum Med Campus III Linz
Belgium AZ Sint Jan Brugge-Oostende av Brugge
Belgium Universitair Ziekenhuis Brussel Brussel
Canada University Of Calgary Calgary Alberta
Canada Montreal Heart Institute Montréal Quebec
Canada Institut Universitaire de Cardiologie et de Pneumo Québec Quebec
Czechia Nemocnice Na Homolce Prague
Denmark Odense Universitetshospital Odense
Finland Helsinki University Hospital Helsinki
France Centre Hospitalier Universitaire de Clermont-Ferrand - Gabriel-Montpied Clermont Ferrand
France Centre Hospitalier Régional Universitaire de Lille Lille
France OC Santé - Clinique du Millénaire Montpellier
France Hôpital Guillaume et René Laënnec - CHU de Nantes Nantes Cedex 1
France Hôpital Européen Georges Pompidou Paris
France Hôpital Haut-Lévêque - CHU de Bordeaux Pessac
France CHU de Rennes - Hôpital Pontchaillou Rennes
France CHRU de Tours - Hôpital Trousseau Saint-Avertin
Germany Herz- und Diabeteszentrum NRW - Ruhr-Universität Bochum Bad Oeynhausen
Germany Elektrophysiologie Bremen - Im Klinikum Links der Weser Bremen
Germany Medizinische Hochschule Hannover Hanover
Germany Robert-Bosch-Krankenhaus Stuttgart
Germany Eberhard Karls Universität Tübingen - Universitätsklinikum Tübingen Tübingen
Greece George Papanikolaou General Hospital Thessaloníki
Hungary Semmelweis Egyetem AOK Budapest
Kuwait Chest Disease Hospital Kuwait
Netherlands Amsterdam UMC - Locatie AMC Amsterdam
Netherlands HagaZiekenhuis - Locatie Leyweg Den Haag
Netherlands Medisch Spectrum Twente Enschede
Netherlands Universitair Medisch Centrum Groningen Groningen
Netherlands Leids Universitair Medisch Centrum (LUMC) Leiden
Netherlands St Antonius Ziekenhuis Nieuwegein
Netherlands Erasmus Medisch Centrum Rotterdam
New Zealand Christ Church Hospital Christchurch
Norway Oslo Universitetssykehus-Rikshospitalet Oslo
Poland Uniwersytecki Szpital Kliniczny w Poznaniu Poznan
Poland Narodowy Instytut Kardiologii - Stefana kardynala Wyszynskiego Warsaw
Poland Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego Warsaw
Poland Slaskie Centrum Chorob Serca Zabrze
Portugal Centro Hospitalar de Lisboa Ocidental, E.P.E. Hospital de Santa Cruz Carnaxide
Portugal Hospital de Santa Maria-Centro Hospitalar Lisboa Norte, EPE Lisboa
Spain Hospital Universitari Bellvitge Barcelona
Spain Hospital Universitario Reina Sofía Córdoba
Spain Hospital Universitario da Coruña Coruña
Spain Hospital Universitari de Girona Doctor Josep Trueta Girona
Spain Hospital Universitario Virgen de las Nieves Granada
Spain Hospital Universitario Son Espases Palma De Mallorca
Spain Hospital Universitario y Politécnico La Fe Valencia
Sweden Sahlgrenska Universitetssjukhuset Göteborg
Sweden Skånes Universitetssjukhus Skåne
Switzerland Inselspital - Universitätsspital Bern Bern
Switzerland Centre Hospitalier Universitaire Vaudois Lausanne
Switzerland Istituto Cardiocentro Ticino Lugano
Switzerland UniversitätsSpital Zürich Zurich
United Kingdom Glenfield Hospital Leicester
United Kingdom Kings College Hospital NHS Foundation Trust London
United States Presbyterian Heart Group Albuquerque New Mexico
United States Texas Cardiac Arrhythmia Research Foundation Austin Texas
United States Northwell Health South Shore University Hospital Bay Shore New York
United States Saint Luke's University Health Network Bethlehem Pennsylvania
United States The University of Alabama at Birmingham Birmingham Alabama
United States Massachusetts General Hospital Boston Massachusetts
United States University of Virginia Medical Center Charlottesville Virginia
United States The Christ Hospital Health Network CRD Cincinnati Ohio
United States Clearwater Cardiovascular Consultants Clearwater Florida
United States Cleveland Clinic Cleveland Ohio
United States OhioHealth Research Institute (OHRI) Columbus Ohio
United States The Ohio State University Wexner Medical Center Columbus Ohio
United States Consultants in Cardiology (Fort Worth) Dallas Texas
United States Duke University Medical Center (DUMC) Durham North Carolina
United States Heart Center of North Texas Fort Worth Texas
United States Hartford Hospital Hartford Connecticut
United States Northwell Health Huntington Hospital Huntington New York
United States Cardiology Associates Medical Group Huntington Park California
United States Baptist Health Jacksonville Florida
United States Saint Luke's Health System Kansas City Missouri
United States University of Kansas Medical Center Research Institute Kansas City Missouri
United States Sparrow Clinical Research Institute Lansing Michigan
United States Norton Heart Specialists Louisville Kentucky
United States Northwell Health North Shore University Hospital Manhasset New York
United States Virtua Health Marlton New Jersey
United States The Stern Cardiovascular Foundation Memphis Tennessee
United States Aurora Cardiovascular Services Milwaukee Wisconsin
United States Minneapolis Heart Institute Foundation Minneapolis Minnesota
United States University of Minnesota Medical Center Fairview Minneapolis Minnesota
United States Atlantic Health System Morristown New Jersey
United States Saint Thomas Research Institute Nashville Tennessee
United States Vanderbilt University Medical Center Nashville Tennessee
United States Long Island Jewish Medical Center New Hyde Park New York
United States New York - Presbyterian Hospital / Weill Cornell Medical Center New York New York
United States NYU Langone Medical Center New York New York
United States Deaconess Specialty Physicians Newburgh Indiana
United States Cardiovascular Institute of Northwest Florida Panama City Florida
United States University of Pittsburgh Medical Center UPMC Passavant Pittsburgh Pennsylvania
United States University of Pittsburgh Medical Center UPMC Presbyterian Pittsburgh Pennsylvania
United States University of Pittsburgh Medical Center UPMC Shadyside Pittsburgh Pennsylvania
United States Baylor Research Institute Plano Texas
United States Hudson Valley Heart Center Poughkeepsie New York
United States Sequoia Hospital Redwood City California
United States Mayo Clinic Rochester Minnesota
United States Washington University School of Medicine Saint Louis Missouri
United States Stanford Hospital & Clinics Stanford California
United States Northwell Health Staten Island University Hospital Staten Island New York
United States Iowa Heart Center West Des Moines Iowa
United States Geisinger Wyoming Valley Medical Center Wilkes-Barre Pennsylvania
United States Michigan Heart Ypsilanti Michigan

Sponsors (1)

Lead Sponsor Collaborator
Medtronic

Countries where clinical trial is conducted

United States,  Austria,  Belgium,  Canada,  Czechia,  Denmark,  Finland,  France,  Germany,  Greece,  Hungary,  Kuwait,  Netherlands,  New Zealand,  Norway,  Poland,  Portugal,  Spain,  Sweden,  Switzerland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Complication-free survival rate To demonstrate 5-year Aurora EV-ICD system-related complication-free survival > 79% 5 years
Secondary System and/or procedure related complication-free survival To estimate the Aurora EV-ICD System and/or procedure related complication-free survival probability as a function of time post-implant Procedure related complications assessed during and after the procedure/surgery; system related complications assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary Abnormal battery depletion complications Characterize the rate of abnormal battery depletion complications as a function of time post-implant Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary Summarize all device system revisions Summarize all device system revisions (e.g., reposition, replacement, explant) including reasons for modification and action taken Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary Patient deaths Summarize patient deaths Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary Patient demographics and baseline medical history Summarize patient demographics and baseline medical history Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary Characterize extracardiac pacing sensation Characterize extracardiac pacing sensation Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary Summarize ATP with spontaneous arrhythmias Summarize ATP with spontaneous arrhythmias Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary Characterize asystole pacing Characterize asystole pacing Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary Characterize sensing and detection Characterize sensing and detection Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
Secondary To characterize defibrillation shock effectiveness for terminating spontaneous VT/VF arrhythmia Characterize high voltage therapy effectiveness on device detected spontaneous ventricular episodes Assessed through the study completion (12 years average), and assessed every year (1 year, 2 years, 3 years, … 12 years)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT05049720 - ExtraVascular Implantable Cardiac Defibrillator Continued Access Study N/A
Completed NCT02941250 - Acute Defibrillation Performance of a Novel Can-less Shock Pathway N/A
Completed NCT01592669 - Passive Leg Raising Attenuates and Delays Tourniquet Deflation-induced Hypotension and Tachycardia N/A
Completed NCT00721136 - Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation N/A
Completed NCT04060680 - Extravascular ICD Pivotal Study N/A
Recruiting NCT04075084 - Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Completed NCT01772576 - Safety and Performance Study of the Reliance 4-Front Lead N/A
Completed NCT01410552 - Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination N/A
Completed NCT00542854 - iPod and Other MP3 Players on ICDs and Pacemakers in Children N/A
Completed NCT02877693 - A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging N/A
Recruiting NCT06038123 - China 3T MRI Study N/A
Completed NCT01754064 - St. Jude Medical Product Longevity and Performance (SCORE) Registry
Completed NCT00402246 - CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision N/A
Active, not recruiting NCT03940066 - Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile N/A
Completed NCT03012568 - Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (SJM) Cardiac Rhythm Management Systems
Completed NCT02772380 - Acute Study to Collect Electrical Signals From the Heart Using a Special Lead N/A
Completed NCT01377051 - Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea Phase 4
Completed NCT00820625 - Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation N/A
Completed NCT03720639 - Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study N/A